Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancy

Not Applicable

• Conditions: Pregnancy; COVID-19 infection; Reproductive Health and Childbirth - Childbirth and postnatal care; Reproductive Health and Childbirth - Complications of newborn; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy; Infection - Other infectious diseases; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12620000449932
• Lead Sponsor: niversity of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-06
• Last Update Posted: 14 April 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

All pregnant women admitted to a participating hospital with COVID-19 during pregnancy

Exclusion Criteria

Suspected COVID-19 not subsequently confirmed on PCR, serology or imaging

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maternal mortality from COVID-19[During pregnancy until 6 weeks postpartum];Perinatal mortality (stillbirth, neonatal death)[During pregnancy and until day 28 in the neonate]